Cargando…
P1622: ANTIPHOSPHOLIPID ANTIBODIES IN CONVALESCENT PLASMA OF DONORS RECOVERED FROM MILD COVID-19
Autores principales: | Blickstein, D., Izak, M., Filipovich- Rimon, T., Garach- Jehoshua, O., Rahimi- Levene, N., Shinar, E., Bar- Chaim, A., Koren-Michowitz, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429639/ http://dx.doi.org/10.1097/01.HS9.0000849344.70911.19 |
Ejemplares similares
-
A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023) -
Niche-modulated and niche-modulating genes in bone marrow cells
por: Cohen, Y, et al.
Publicado: (2012) -
Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
por: Rahimi-Levene, Naomi, et al.
Publicado: (2022) -
International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study
por: Ofek, Fanny, et al.
Publicado: (2019) -
The increased expression of 14q32 small nucleolar RNA transcripts in promyelocytic leukemia cells is not dependent on PML–RARA fusion gene
por: Cohen, Y, et al.
Publicado: (2012)